Mankind Pharma Ltd. (MANKIND) Financial Statements

13 Followers

Mankind Pharma Ltd. Financial Overview

Mankind Pharma Ltd.'s market cap is currently ₹843.08B. The company's EPS TTM is ₹12.5; its P/E ratio is 55.46; and it has a dividend yield of 0.04%. Mankind Pharma Ltd. is scheduled to report earnings on February 3, 2026, and the estimated EPS forecast is ₹10.34. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Income Statement
Total Revenue	₹ 122.07B	₹ 102.59B	₹ 87.49B	₹ 77.82B	₹ 62.14B
Gross Profit	₹ 86.38B	₹ 70.02B	₹ 57.87B	₹ 53.12B	₹ 43.89B
Operating Income	₹ 25.16B	₹ 22.39B	₹ 16.42B	₹ 18.84B	₹ 16.06B
EBITDA	₹ 35.58B	₹ 28.04B	₹ 20.37B	₹ 21.97B	₹ 18.30B
Net Income	₹ 19.91B	₹ 19.13B	₹ 12.82B	₹ 14.33B	₹ 12.65B
Balance Sheet
Cash & Short-Term Investments	₹ 22.45B	₹ 34.56B	₹ 15.29B	₹ 12.79B	₹ 20.04B
Total Assets	₹ 277.60B	₹ 119.63B	₹ 97.15B	₹ 91.48B	₹ 63.73B
Total Debt	₹ 85.11B	₹ 2.07B	₹ 1.70B	₹ 8.73B	₹ 2.41B
Net Debt	₹ 79.57B	₹ -1.75B	₹ -1.34B	₹ 5.71B	₹ 734.77M
Total Liabilities	₹ 131.91B	₹ 23.87B	₹ 20.67B	₹ 28.31B	₹ 15.10B
Stockholders' Equity	₹ 143.32B	₹ 93.63B	₹ 74.35B	₹ 61.55B	₹ 47.22B
Cash Flow
Free Cash Flow	₹ 19.53B	₹ 17.70B	₹ 9.53B	₹ -14.26B	₹ 8.25B
Operating Cash Flow	₹ 24.13B	₹ 21.52B	₹ 17.85B	₹ 9.20B	₹ 11.37B
Investing Cash Flow	₹ -126.92B	₹ -20.82B	₹ -10.54B	₹ -13.69B	₹ -12.22B
Financing Cash Flow	₹ 102.33B	₹ 52.66M	₹ -7.40B	₹ 6.05B	₹ -78.11M

Currency in INR

Mankind Pharma Ltd. Earnings and Revenue History

Income Statement >

Mankind Pharma Ltd. Debt to Assets

Balance Sheet >

Mankind Pharma Ltd. Cash Flow

Cash Flow >

Mankind Pharma Ltd. Forecast EPS vs Actual EPS

Earnings >